HSU ERIC C 4
4 · InMed Pharmaceuticals Inc. · Filed Dec 19, 2025
Insider Transaction Report
Form 4
HSU ERIC C
Sr VP, Pre-Clinical Res/Dev
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-12-19+13,000→ 18,280 totalExercise: $1.29Exp: 2030-12-18→ Common shares (13,000 underlying)
Footnotes (1)
- [F1]The options were granted on 12/19/2025 and will vest in equal installments monthly, in arrears, over 36 months (1/36 per month)